Cyclacel Pharmaceuticals (CYCC) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-6.23
-4.21
-2.2
-0.18

Details

Expected EPS
-0.54
Actual EPS
-0.18
Surprise EPS
0.36
Surprise Percent
+66.67%

Description

Cyclacel Pharmaceuticals (CYCC) has reported earnings of -0.18 per share for Q4 2024.

0 Comments

Share your thoughts